The luseogliflozin drug market is anticipated to grow at a significant CAGR 4% during the forecast period (2022-2028). Luseogliflozin drug is prescribed in the treatment of type 2 diabetes. The rise in type 2 diabetes-related comorbidities has fueled a more aggressive approach in treatment and the use of multiple-drug therapies. Type 2 diabetes is a […]
